Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
90.81
-8.48 (-8.54%)
Jun 2, 2026, 12:43 PM EDT - Market open
Inhibrx Biosciences Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Inhibrx Biosciences stock has a consensus rating of "Buy" and an average price target of $277.5. The average 1-year stock price forecast is 205.58% higher than the current stock price, while the lowest is $230 (+153.28%) and the highest is $325 (+257.89%).
Price Target: $277.5 (+205.58%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inhibrx Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Oct '25 | Nov '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $230 | Buy | Maintains | $230 | +153.28% | May 16, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $300 → $325 | Buy | Reiterates | $300 → $325 | +257.89% | May 15, 2026 |
Financial Forecast
Revenue This Year
n/a
from 1.30M
Revenue Next Year
55.13M
EPS This Year
-7.96
from -9.04
EPS Next Year
-5.33
from -7.96
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 56.8M | ||||||
| Avg | n/a | 55.1M | ||||||
| Low | n/a | 53.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -5.74 | -2.93 | ||||
| Avg | -7.96 | -5.33 | ||||
| Low | -9.95 | -7.52 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.